Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial

NCT05753839 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT05753839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05753839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial
Lead sponsor
Yonsei University
Phase
Not applicable
Overall status
Recruiting
Start date
July 31, 2023
Completion date
December 31, 2031
Enrollment
40 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

clear cell renal cell carcinoma metastatic, kidney cancer, synchronous neoplasm